The 80th Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 1-9C AML: Genetic abnormalities

Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Takashi Taga (Department of Pediatrics, Shiga University of Medical Science, Japan)

【E】

Kyogo Suzuki1, Asahito Hama1,2, Yusuke Okuno3, Nozomu Kawashima1, Eri Nishikawa1, Atsushi Narita1, Hirotoshi Sakaguchi2, Nao Yoshida2, Hideki Muramatsu1, Nobuhiro Nishio3, Koji Kato2, Seiji Kojima1, Keon Hee Yoo4, Yoshiyuki Takahashi1 (1.Department of Pediatrics, Nagoya University, Nagoya, Japan, 2.Children's Medical Center, JRC Nagoya First Hospital, Nagoya, Japan, 3.Center for Advanced Medicine/Clinical Research, Nagoya University, Nagoya, Japan, 4.Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University, Seoul, Korea)

Koji Sasaki1, Norio Shiba1,2, Yuri Uchiyama3, Junji Ikeda1, Masahiro Yoshitomi1, Yuko Shimosato1, Mayu Tokumasu4, Hidemasa Matsuo4, Kenichi Yoshida5, Kentaro Ohki2, Genki Yamato2, Yusuke Hara7, Akitoshi Kinoshita8, Daisuke Tomizawa9, Takashi Taga10, Souichi Adachi4, Akio Tawa11, Keizo Horibe12, Naomichi Matsumoto3, Shuichi Ito1, Yasuhide Hayashi2 (1.Department of Pediatrics, Yokohama City University, Kanagawa, Japan, 2.Department of Hematology/Oncology, Gunma Children's Medical Center, Gunma, Japan, 3.Department of Human genetics, Yokohama City University, Kanagawa, Japan, 4.Department of Human Health Sciences, Kyoto University, Kyoto, Japan, 5.Department of Biology and Oncology, Kyoto University, Kyoto, Japan, 6.Department of Hematology and Oncology, NCCHD, Tokyo, Japan, 7.Dept. Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan, 8.Department of Pediatrics, St. Marianna University, Kanagawa, Japan, 9.Children's Cancer Center, NCCHD, Tokyo, Japan, 10.Department of Pediatrics, Shiga University of Medical Science, Shiga, Japan, 11.Department of Pediatrics, NHO Osaka National Hospital, Osaka, Japan, 12.Clinical Research Center, NHO Nagoya Medical Center, Aichi, Japan)

Masahiro Onozawa1, Daisuke Hidaka1, Junichi Hashiguchi1, Naohiro Miyashita1, Shinichi Fujisawa2, Eiko Hayase1,2, Satoshi Yamamoto3, Yutaka Tsutsumi4, Yoshihito Haseyama5, Takahiro Nagashima6, Akio Mori7, Shuichi Ota8, Hajime Sakai9, Toshimichi Ishihara10, Takuto Miyagishima11, Yasutaka Kakinoki12, Mitsutoshi Kurosawa13, Hajime Kobayashi14, Hiroshi Iwasaki15, Takeshi Kondo7, Takanori Teshima1,2 (1.Department of Hematology, Hokkaido Univ., Sapporo, Japan, 2.Hokkaido Univ. Hospital, Laboratory and Transfusion Medicine, Sapporo, Japan, 3.Department of Hematology, Sapporo City General Hospital, Sapporo, Japan, 4.Hakodate Municipal Hospital, Hakodate, Japan, 5.Tonan Hospital, Sapporo, Japan, 6.Japanese Red Cross Kitami Hospital, Kitami, Japan, 7.Aiiku Hospital, Sapporo, Japan, 8.Sapporo Hokuyu Hospital, Sapporo, Japan, 9.Teine Keijinkai Hospital, Sapporo, Japan, 10.Kin-ikyo Chuo Hospital, Sapporo, Japan, 11.Kushiro Rosai Hospital, Kushiro, Japan, 12.Asahikawa City Hospital, Asahikawa, Japan, 13.Hokkaido Cancer Center, Sapporo, Japan, 14.Obihiro Kosei General Hospital, Obihiro, Japan, 15.Sapporo Kosei General Hospital, Sapporo, Japan)

Ryosaku Inagaki1,2,3, Masahiro Nakagawa1,2, Yasuhito Nannya1, Lanying Zhao1, June Takeda1, Akinori Yoda1, Ayana Kon1, Tetsuichi Yoshizato1, Hisashi Tsurumi4, Hideki Makishima1, Seishi Ogawa1 (1.Department of Pathology and Tumor Biology, Kyoto Univ., Kyoto, Japan, 2.DSK Project, Medical Innovation Center, Kyoto University, 3.Sumitomo Dainippon Pharma Co., Ltd., 4.Department of Hematology, Gifu University)